Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer

Clinical trial NCT03126812 · COMPLETED

Trial details

NCT number: NCT03126812
Sponsor: The Netherlands Cancer Institute
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Stage IV Peritoneal Cancer Fallopian Tube Cancer

Start date: 2017-11-01
Primary completion: 2023-06-01
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.